1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Duodenal Obstruction: new trials by email Literature Review of Duodenal Obstruction trials Research Report on Duodenal Obstruction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin, Plavix (clopidogrel 75 mg) and aspirin - Acute Coronary Syndrome, Myocardial Infarction | Phase 3 | Terminated | Cogentus Pharmaceuticals | 5000 | 2007-12-01 | 2009-01-28 |
Acute Coronary Syndrome (1) · Cerebrovascular Disorders (1) · Coronary Artery Disease (1) · Coronary Thrombosis (1) · Duodenal Ulcer (1) · Dyspepsia (1) · Esophagitis, Peptic (1) · Gastric Outlet Obstruction (1) · Gastroesophageal Reflux (1) · Gastrointestinal Hemorrhage (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · Non-ST Elevated Myocardial Infarction (1) · Peptic Ulcer (1)
Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Coronary Disease (1) · Deglutition Disorders (1) · Digestive System Diseases (1) · Duodenal Diseases (1) · Embolism and Thrombosis (1) · Esophageal Diseases (1) · Esophageal Motility Disorders (1) · Esophagitis (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1)
Aspirin (1) · Clopidogrel (1) · Omeprazole (1)
Australia (1) · Bulgaria (1) · Canada (1) · Chile (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Mexico (1) · Poland (1) · Puerto Rico (1) · Romania (1) · Slovakia (1) · Ukraine (1)